NSRX Nasus Pharma Ltd.
P/E
--
Forward P/E
--
Price/Sales
--
Beta
--
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🟢 NSRX is trading 5.4% up today, extending a multi-day rebound amid a broader market rally
NSRX is trading 5.4% up today at $3.50, extending a multi-day rebound from the low-$3 range amid a broader risk-on mood in U.S. equities. • The move appears...
🔴 NSRX is trading 6% down today as it gives back recent gains ahead of investor events
NSRX is trading at approximately $3.11 (6% down), pulling back as it gives back a portion of its recent rally leading into upcoming investor presentations. •...
Nasus Pharma Ltd. Q1 2026 Earnings Preview: What Analysts Expect on June 24, 2026
Consensus revenue is projected at $0.00 million as the company remains in its pre-commercial development phase, with EPS expected at -$0.27 against a current...